logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tracy L. Diamond

Merck & Co., Inc.
H指数:15
被引数:2,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance–Associated Mutations or M184I/V in Proviral DNA

尽管存在基线非核苷类逆转录酶抑制剂耐药相关突变或原病毒DNA中的M184I/V，每日多拉维林/伊拉曲韦（100/0.25 mg）切换疗法在48周内维持病毒抑制

The Journal of Infectious Diseases
IF0
2026-05-290
OA
Tracy L Diamond; Anjana Grandhi; Monica Fuszard; Yayun Xu; Uchechukwu Nwoke; Ying Zhang; Stephanie O Klopfer; Karen Eves; Jaime Benner; Mengchun Li; Wayne Greaves; Rima Lahoulou; Jason Kim; Michelle C Fox; Ernest Asante-Appiah; null
Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial

固定剂量每日多拉维林（100 mg）联合伊拉曲拉韦（0·25 mg）与比克替拉韦、恩曲他滨和替诺福韦艾拉酚胺用于初始HIV-1治疗：一项III期、随机、对照、双盲、非劣效性试验的48周结果

The Lancet HIV
IF0
2026-02-250
PRE
Jürgen K Rockstroh; Sheetal Kassim; Roger Paredes; Christopher Bettacchi; Gary Sinclair; Anchalee Avihingsanon; Nelly Mugo; Jean-Michel Molina; Brenda Crabtree Ramírez; Hiroyuki Gatanaga; Yayun Xu; Stephanie O Klopfer; Tracy L Diamond; Mary Vesnesky; Luisa M Stamm; Michelle C Fox; Mary L Pisculli
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, multicentre, randomised, controlled, double-blind, non-inferiority trial

在病毒学抑制的成人中，每天一次使用固定剂量的多拉韦林 (100 mg) 和islatravir (0·25 mg)，HIV-1使用bicegravir，恩曲他滨和替诺福韦alafenamide: 3期，多中心，随机，对照的48周结果，双盲，非劣效性试验

The Lancet
IF97.3
2026-02-050
PRE
Amy E Colson; Anthony M Mills; Moti N Ramgopal; Christopher Bettacchi; Olayemi O Osiyemi; Federico Hinestrosa; Gordon Crofoot; Harold P Katner; Hiroyuki Gatanaga; Margaret Johnson; Tracy L Diamond; Erika Barninger; Karen Eves; Feng-Hsiu Su; Yayun Xu; Stephanie O Klopfer; Luisa M Stamm; Michelle C Fox; Rima Lahoulou
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial

在接受口服抗逆转录病毒治疗的HIV-1的病毒学抑制成人中，每天一次改用固定剂量的doravirine (100 mg) 和islatravir (0·25 mg): 3期，多中心，随机，开放标签，非劣效性试验的48周结果

The Lancet
IF97.3
2026-02-050
PRE
Chloe Orkin; Rosie Mngqibisa; Juan Diego Velez; Princy Kumar; Dominique L Braun; Andrew Carr; Mark Bloch; Sharon Walmsley; Pablo Tebas; Yoshiyuki Yokomaku; Tracy L Diamond; Beth Jackson; Karen Eves; Anjana Grandhi; Monica Fuszard; Stephanie O Klopfer; Luisa M Stamm; Michelle C Fox; Jason Kim
Weekly Oral Prophylaxis With MK-8527 Protects Rhesus Macaques From Intrarectal Challenge With Simian-Human Immunodeficiency Virus

每周口服MK-8527预防可保护恒河猴免受经直肠感染人猿免疫缺陷病毒的挑战

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2025-12-010
OAAI
Diamond, Tracy L.; Kapoor, Yash; Li, Fangbiao; Wan, Bang-Lin; Boddicker, Melissa A.; Maxwell, Jill W.; Ngo, Winnie; Fontenot, Jane A.; Soileau, Kelly A.; Villinger, Francois J.; Grobler, Jay A.; Wang, Shubing; Fillgrove, Kerry L.; Lange, Henry S.; Asante-Appiah, Ernest
Discovery of [11C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR2 Negative Allosteric Modulators
ACS MEDICINAL CHEMISTRY LETTERS
IF4
2023-06-132
OA
Perkins, James J. J.; McQuade, Paul; Bungard, Christopher J. J.; Diamond, Tracy L. L.; Gantert, Liza T. T.; Gotter, Anthony L. L.; Hanney, Barbara; Hills, Ivory D. D.; Hurzy, Danielle M. M.; Joshi, Aniket; Kern, Jonathan T. T.; Schlegel, Kelly-Ann S.; Manikowski, Jesse J. J.; Meng, Zhaoyang; O'Brien, Julie A. A.; Roecker, Anthony J. J.; Smith, Sean M. M.; Uslaner, Jason M. M.; Hostetler, Eric; Meissner, Robert S. S.
Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1
SCIENCE TRANSLATIONAL MEDICINE
IF14.6
2023-02-2211
PRE
Balibar, Carl J.; Klein, Daniel J.; Zamlynny, Beata; Diamond, Tracy L.; Fang, Zhiyu; Cheney, Carol A.; Kristoff, Jan; Lu, Meiqing; Bukhtiyarova, Marina; Ou, Yangsi; Xu, Min; Ba, Lei; Carroll, Steven S.; El Marrouni, Abdellatif; Fay, John F.; Forster, Ashley; Goh, Shih Lin; Gu, Meigang; Krosky, Daniel; Rosenbloom, Daniel I. S.; Sheth, Payal; Wang, Deping; Wu, Guoxin; Zebisch, Matthias; Zhao, Tian; Zuck, Paul; Grobler, Jay; Hazuda, Daria J.; Howell, Bonnie J.; Converso, Antonella
A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells
ACS CHEMICAL BIOLOGY
IF3.8
2022-08-3118
PRE
Moore, Keith P.; Schwaid, Adam G.; Tudor, Matthew; Park, Sangho; Beshore, Douglas C.; Converso, Antonella; Shipe, William D.; Anand, Rajan; Lan, Ping; Moningka, Remond; Rothman, Deborah M.; Sun, Wanying; Chi, An; Cornella-Taracido, Ivan; Adam, Gregory C.; Bahnck-Teets, Carolyn; Carroll, Steven S.; Fay, John F.; Goh, Shih Lin; Lusen, Jeffrey; Quan, Shuo; Rodriguez, Silveria; Xu, Min; Andrews, Christine L.; Song, Cheng; Filzen, Tracey; Li, Jing; Hollenstein, Kaspar; Klein, Daniel J.; Lammens, Alfred; Lim, U-Ming; Fang, Zhiyu; McHale, Carolyn; Li, Yuan; Lu, Meiqing; Diamond, Tracy L.; Howell, Bonnie J.; Zuck, Paul; Balibar, Carl J.
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors
ACS MEDICINAL CHEMISTRY LETTERS
IF4
2017-11-2137
OAAI
Bungard, Christopher J.; Williams, Peter D.; Schulz, Jurgen; Wiscount, Catherine M.; Holloway, M. Katharine; Loughran, H. Marie; Manikowski, Jesse J.; Su, Hua-Poo; Bennett, David J.; Chang, Lehua; Chu, Xin-Jie; Crespo, Alejandro; Dwyer, Michael P.; Keertikar, Kartik; Morriello, Gregori J.; Stamford, Andrew W.; Waddell, Sherman T.; Zhong, Bin; Hu, Bin; Jo, Tao; Diamond, Tracy L.; Bahnck-Teets, Carolyn; Carroll, Steven S.; Fay, John F.; Min, Xu; Morris, William; Ballard, Jeanine E.; Miller, Michael D.; McCauley, John A.
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group
ACS MEDICINAL CHEMISTRY LETTERS
IF4
2016-05-1122
OAAI
Bungard, Christopher J.; Williams, Peter D.; Ballard, Jeanine E.; Bennett, David J.; Beaulieu, Christian; Bahnck-Teets, Carolyn; Carroll, Steve S.; Chang, Ronald K.; Dubost, David C.; Fay, John F.; Diamond, Tracy L.; Greshock, Thomas J.; Hao, Li; Holloway, M. Katharine; Felock, Peter J.; Gesell, Jennifer J.; Su, Hua-Poo; Manikowski, Jesse J.; McKay, Daniel J.; Miller, Mike; Min, Xu; Molinaro, Carmela; Moradei, Oscar M.; Nantermet, Philippe G.; Nadeau, Christian; Sanchez, Rosa I.; Satyanarayana, Tummanapalli; Shipe, William D.; Singh, Sanjay K.; Vouy Linh Truong; Vijayasaradhi, Sivalenka; Wiscount, Catherine M.; Vacca, Joseph P.; Crane, Sheldon N.; McCauley, John A.

研究方向

暂未获取到该数据
J
Jay A. Grobler
H 指数:37论文数:127被引数:7,151
M
Min Xu
H 指数:14论文数:46被引数:1,006
F
Frederic D. Bushman
H 指数:139论文数:789被引数:12.4万
S
Shih Lin Goh
H 指数:22论文数:36被引数:2,189
S
Steven S. Carroll
H 指数:37论文数:110被引数:5,434
D
Daniel J. Klein
H 指数:30论文数:116被引数:4,529
E
Ernest Asante‐Appiah
H 指数:26论文数:119被引数:2,607
W
Winnie Ngo
H 指数:9论文数:17被引数:629
B
Baek Kim
H 指数:54论文数:342被引数:1.0万
B
Bonnie J. Howell
H 指数:33论文数:127被引数:6,470